Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study.

Maryam SaeedGerman Tapia Inger AriansenLars C SteneIngebjørg SeljeflotGrethe S TellTorild SkrivarhaugGeir Joner

Published in: Diabetes care (2021)

Galectin-3 was significantly associated with future CHD in subjects with type 1 diabetes, and if the results are replicated in larger studies, it may aid in prediction together with conventional risk factors for CHD.

Keyphrases

type diabetes
current status
cardiovascular disease
glycemic control
insulin resistance
case control
early life
childhood cancer
metabolic syndrome